Pekin Hardy Strauss Inc. decreased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 13.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,732 shares of the biopharmaceutical company’s stock after selling 906 shares during the period. Pekin Hardy Strauss Inc.’s […]
Kingsview Wealth Management LLC boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 52.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 33,713 shares of the biopharmaceutical company’s stock after purchasing an additional 11,587 shares during the quarter. Kingsview Wealth […]
Simplify Asset Management Inc. raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 8.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,262 shares of the biopharmaceutical company’s stock after purchasing an additional 343 […]
Simplify Asset Management Inc. raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 8.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,262 shares of the biopharmaceutical company’s stock after purchasing an additional 343 […]
Ranch Capital Advisors Inc. trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 21.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,945 shares of the biopharmaceutical company’s stock after selling 4,098 shares during the […]